The purpose of this study is to compare renal toxicity of Iodixanol and Iopromide in patients with renal dysfunction.
The study is designed to compare renal toxicity of Iodixanol and Iopromide after coronary angiography or percutaneous coronary intervention (PCI) in patient with Chronic Kidney Disease, considering original renal function and adequate hydration. The risk of varying degree of renal impairment, changes of serum Cys C level will also be evaluated.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Enrollment
200
Anhui Provincial Hospital
Hefei, Anhui, China
to evaluate the change in Glomerular Filtration Rate levels by Estimated Glomerular Filtration Rate
Time frame: days 3 and 7
In each group(Iodixanol group and Iopromide group), the proportion of patients exhibiting an increases of serum creatinine in different range(<10%,10%~25%, and ≥25%), comparing with baseline level.
Time frame: days 3 and 7
Incidence of hemodialysis
Time frame: days 3 and 7
Changes of Cystatin C level from baseline
Time frame: days 1 and 3
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Peking University First Hospital
Beijing, Beijing Municipality, China
RECRUITINGFujian Medical University Union Hospital
Fuzhou, Fujian, China
NOT_YET_RECRUITINGGuangdong Academy Of Medical Sciences Guangdong General Hospital
Guangzhou, Guangdong, China
NOT_YET_RECRUITINGThe First Affiliated Hospital Of Guangxi Medical University
Nanning, Guangxi, China
RECRUITINGThe People's Hospital Of Hebei Province
Shijiazhuang, Hebei, China
NOT_YET_RECRUITINGHenan Provincial People's Hospital
Luoyang, Henan, China
NOT_YET_RECRUITINGThe Second Affiliated Hospital To Nanchang University
Nanchang, Jiangxi, China
NOT_YET_RECRUITINGThe People's Hospital Of Liaoning Province
Shenyang, Liaoning, China
RECRUITINGThe Affiliated Hospital Of Medical College Qingdao University
Qingdao, Shandong, China
NOT_YET_RECRUITING...and 9 more locations